dc.contributorUniversidade Estadual Paulista (Unesp)
dc.date.accessioned2014-05-20T13:24:51Z
dc.date.accessioned2022-10-05T13:15:01Z
dc.date.available2014-05-20T13:24:51Z
dc.date.available2022-10-05T13:15:01Z
dc.date.created2014-05-20T13:24:51Z
dc.date.issued2009-10-15
dc.identifierCarbohydrate Polymers. Oxford: Elsevier B.V., v. 78, n. 3, p. 557-563, 2009.
dc.identifier0144-8617
dc.identifierhttp://hdl.handle.net/11449/7820
dc.identifier10.1016/j.carbpol.2009.05.021
dc.identifierWOS:000269991800029
dc.identifier5361569184579557
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/3884588
dc.description.abstractA relative simple drug delivery system in the form of coevaporates were prepared and analyzed. They were based on chitosan (CS), a polysaccharide that undergoes specific degradation by colonic enzymes. Enteric polymers, namely cellulose acetate phtalate (CAP) and hydroxypropylmethylcellulose phtalate (HPMCP), were incorporated, due to their insolubility in environments presenting low pH values. The systems were physically characterized, demonstrating that CS affects the swelling properties of the samples. The ability of these systems to reach the colonic region was assessed in vitro in simulated gastric, enteric and colonic fluids. Korsmeyer-Peppas and Weibull models were applied to analyze the drug release kinetics and the results suggested that the drug release from the coevaporates follows a complex release mechanism, in which several processes, including diffusion, swelling, and erosion. are involved and may occur simultaneously. The results demonstrated that it is possible to prepare relative simple drug carrier systems able to reach the colonic environment, since their swelling capacity can be controlled by varying the composition. (c) 2009 Elsevier Ltd. All rights reserved.
dc.languageeng
dc.publisherElsevier B.V.
dc.relationCarbohydrate Polymers
dc.relation5.158
dc.relation1,428
dc.rightsAcesso restrito
dc.sourceWeb of Science
dc.subjectColonic drug delivery
dc.subjectChitosan
dc.subjectCoevaporates
dc.subjectMetronidazole
dc.titleIn vitro characterization of coevaporates containing chitosan for colonic drug delivery
dc.typeArtigo


Este ítem pertenece a la siguiente institución